![Christopher Missling](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Missling
Geen lopende functies
Vermogen: 4 M $ op 31-08-2026
Profiel
Dr. Christopher U.
Missling was previously employed as a Head-Financial Planning by Aventis, Inc., a Head-Healthcare Investment Banking by Brimberg & Co., a CFO & Senior Vice President-Strategic Operations by Curis, Inc., and a Chief Financial Officer by ImmunoGen, Inc. He also served on the board at Anavex Life Sciences Corp.
He received his graduate degree from Ludwig-Maximilians-Universität München, an MBA from WHU-Otto Beisheim School of Management, an MBA from Kellogg School of Management and a doctorate degree from Ludwig-Maximilians-Universität München.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-07-2026 | 1.510.165 ( 1,63% ) | 4 M $ | 31-08-2026 |
Eerdere bekende functies van Christopher Missling
| Bedrijven | Functie | Einde |
|---|---|---|
| ANAVEX LIFE SCIENCES CORP. | Algemeen Directeur | 30-04-2026 |
Aventis, Inc.
 Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Corporate Officer/Principal | - |
Brimberg & Co.
 Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
| IMMUNOGEN, INC. | Financieel Directeur/CFO | - |
| CURIS, INC. | Financieel Directeur/CFO | - |
Opleiding van Christopher Missling
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Curis, Inc.
 Curis, Inc. BiotechnologyHealth Technology Develops therapeutics to treat cancer | Health Technology |
Aventis, Inc.
Aventis, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
Brimberg & Co.
Brimberg & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
WHU-Otto Beisheim School of Management
 WHU-Otto Beisheim School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anavex Life Sciences Corp.
 Anavex Life Sciences Corp. BiotechnologyHealth Technology Engages in the development of innovative drug compounds | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
